Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995 Jul 5;274(1):35-43 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/7791256.
Compare quality appraisals for each clinical question
- How can risk assessment and quality assurance activities minimise errors in cancer therapy?
- What governance processes, policies and procedures should be in place for the safe provision of cancer therapy?